Neutrophil-to-Lymphocyte Ratio-Based Model for Predicting Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors in Thailand Single-center retrospective ...
Time-of-day immunotherapy may represent a modifiable factor in cancer care, with earlier immune checkpoint inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results